Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01848548 · ClinicalTrials.gov registry record
Superior Laryngeal Nerve Block For Awake Endotracheal Intubation Study
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- 25
- Enrollment target
NCT01848548 is a clinical trial that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 25 participants.
The verdict
NCT01848548 was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- 25 participants
- Enrollment target
Study Summary
Awake tracheal intubation is the standard management for patients as risk for airway compromise. It is also commonly done in cases where there is significant cervical spine pathology i.e. cervical myelopathy or instability. The anesthetic technique used for the awake intubation is crucial to the patient's safety. One of the most important aspects of the anesthetic technique is airway anesthesia prior to placement of an endotracheal tube. The superior laryngeal nerve is responsible for mediating the cough reflex around the vocal cords. The investigators have developed an approach to reliably block the superior laryngeal nerve by injecting local anesthetic near the nerve in a unique approach. Injecting local anesthetic into or through the thyrohyoid membrane will effectively block the superior laryngeal nerve
Interventions
- PROCEDURE Superior Laryngeal Nerve Block using the Thyrohyoid Membrane as an Anatomic Landmark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2013-04 |
| Est. Completion | 2017-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01848548
The ClinicalTrials.gov registry entry for NCT01848548 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Superior Laryngeal Nerve Block using the Thyrohyoid Membrane as an Anatomic Landmark is the first listed.
NCT01848548 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01848548 about?
NCT01848548 is a clinical study titled "Superior Laryngeal Nerve Block For Awake Endotracheal Intubation Study". Awake tracheal intubation is the standard management for patients as risk for airway compromise. It is also commonly done in cases where there is significant cervical spine pathology i.e. cervical myelopathy or instability. The anesthetic technique used for the awake intubation is crucial to the pat...
What is the current status of trial NCT01848548?
This trial is currently terminated. The enrollment target is 25 participants. The study started on 2013-04. Estimated completion is 2017-07.
What interventions are being tested in trial NCT01848548?
The interventions under investigation include: Superior Laryngeal Nerve Block using the Thyrohyoid Membrane as an Anatomic Landmark (PROCEDURE).
Who is sponsoring clinical trial NCT01848548?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.